Prophylactic prednisolone for the prevention of early and intermediate adverse effects of radioactive iodine therapy in patients with thyroid cancer: study protocol for a single-centre, phase II/III, randomized, double-blinded, placebo-controlled clinical trial

Peer Review reports

Original Submission
2 Apr 2020	Submitted	Original manuscript
9 Jul 2020	Reviewed	Reviewer Report - Alexander Gough
19 Jul 2020	Reviewed	Reviewer Report - Gaosong Wu
21 Aug 2020	Author responded	Author comments - Umesh Jayarajah
Resubmission - Version 2
21 Aug 2020	Submitted	Manuscript version 2
3 Sep 2020	Reviewed	Reviewer Report - Gaosong Wu
5 Sep 2020	Reviewed	Reviewer Report - Alexander Gough
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
16 Sep 2020	Editorially accepted
29 Sep 2020	Article published	10.1186/s13063-020-04744-x

Back to article page